EQS-News: Medios AG presents growth strategy and announces medium-term targets at Capital Markets Day 2022
Expansion of the Patient-Specific Therapies segment by entering into the manufacture of personalized medicine (including RNA, gene and cell therapies)
EQS-News: Medios AG / Key word(s): Capital Markets Day Medios AG presents growth strategy and announces medium-term targets at Capital Markets Day 2022 24.11.2022 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Press release Medios AG presents growth strategy and announces medium-term targets at Capital Markets Day 2022
Berlin, November 24, 2022 – Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, presents the Company's adapted growth strategy and the corresponding mid-term outlook at today's Capital Markets Day. The strategy is in line with Medios' mission to build regional supply networks to achieve the best comprehensive patient care and comprises three growth strands: in addition to strengthening its core business in Germany, the Company intends to expand drug manufacturing into other European countries and plans to further diversify its business model by entering into the manufacture of personalized medicine. 1 EBITDA is defined as profit for the period before deduction of interest, taxes, depreciation and amortization. EBITDA pre is adjusted for special charges for stock options and M&A activities. 2 Company information ------------------- About Medios AG
24.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Medios AG |
Heidestraße 9 | |
10557 Berlin | |
Germany | |
Phone: | +49 30 232 566 - 800 |
Fax: | +49 30 232 566 - 801 |
E-mail: | [email protected] |
Internet: | www.medios.ag |
ISIN: | DE000A1MMCC8 |
WKN: | A1MMCC |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1495023 |
End of News | EQS News Service |
|
1495023 24.11.2022 CET/CEST